We are live on ! Find out more
SA

Sicart Associates Portfolio holdings

AUM $389M
1-Year Est. Return 42.46%
This Fund
S&P 500
This Quarter Est. Return
+11.74%
1 Year Est. Return
+42.46%
3 Year Est. Return
+89.06%
5 Year Est. Return
+118.65%
10 Year Est. Return
–
AUM
$286M
AUM Growth
-$3.33M
Cap. Flow
-$27M
Cap. Flow %
-9.44%
Top 10 Hldgs %
48.02%
Holding
78
New
12
Increased
6
Reduced
39
Closed
6

Top Buys

Rank Stock Value
1
GH icon
Guardant Health
GH
+$1.24M
2
LOW icon
Lowe's Companies
LOW
+$1.05M
3
PG icon
Procter & Gamble
PG
+$704K
4
WMT icon
Walmart Inc
WMT
+$531K
5
GIS icon
General Mills
GIS
+$384K

Top Sells

Rank Stock Value
1
GILD icon
Gilead Sciences
GILD
+$11.4M
2
IBB icon
iShares Biotechnology ETF
IBB
+$5.82M
3
GLW icon
Corning
GLW
+$3.16M
4
FDX icon
FedEx
FDX
+$1.41M
5
GLD icon
SPDR Gold Trust
GLD
+$1.35M

Sector Composition

Rank Sector Weight
1 Communication Services 18.38%
2 Consumer Staples 10.5%
3 Materials 10.28%
4 Healthcare 10.04%
5 Consumer Discretionary 9.49%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
QQQ icon
76
Invesco QQQ Trust
QQQ
$453B
– –
-441
Closed -$207K
XBI icon
77
State Street SPDR S&P Biotech ETF
XBI
$9.95B
– –
-5,103
Closed -$414K
XOM icon
78
ExxonMobil
XOM
$644B
– –
-4,272
Closed -$508K
1 2 3
4

Similar funds

AIM
Aigen Investment Management New York $389M AUM 16.77% 1-Year Est. Return
WCM
Winthrop Capital Management Carmel, Indiana $389M AUM 16.76% 1-Year Est. Return
HP
Hilltop Partners Mishawaka, Indiana $390M AUM 16.72% 1-Year Est. Return
P8IP
Pier 88 Investment Partners San Francisco, California $390M AUM 10.13% 1-Year Est. Return
PFPGI
Patriot Financial Partners GP II Radnor, Pennsylvania $388M AUM
PG
Prostatis Group Hanover, Maryland $391M AUM 20.37% 1-Year Est. Return
S
SimplyRich Carlsbad, California $391M AUM 24.42% 1-Year Est. Return
LHC
Little House Capital Braintree, Massachusetts $387M AUM 27.85% 1-Year Est. Return

Sicart Associates's Q2 2025 Portfolio in Review

As of Q2 2025, Sicart Associates held 78 positions worth $286M, down 1.2% from $289M the previous quarter. Its ten largest holdings account for 48% of the portfolio.

Sicart Associates withdrew a net $27M in Q2 2025, closing 6 positions and reducing 39 holdings. Its most notable exit was Gilead Sciences, an estimated $11.4M position sold in full.

By sector, the portfolio is most concentrated in Communication Services at 18% of assets, up from 15% a quarter earlier, followed by Consumer Staples and Materials.

Against the trend, Sicart Associates opened a new position in Lowe's Companies worth $1.04M.

  • Sicart Associates's largest Q2 2025 buy was Lowe's Companies: 4,689 shares worth $1.04M.
  • Sicart Associates added most to Guardant Health in Q2 2025, an estimated $1.24M increase.
  • Sicart Associates's biggest Q2 2025 reduction was Corning, cutting an estimated $3.16M.
  • Sicart Associates fully exited Gilead Sciences in Q2 2025, selling an estimated $11.4M.
  • Sicart Associates's ten largest holdings make up 48% of its $286M portfolio in Q2 2025.
  • Sicart Associates opened 12 new positions and closed 6 in Q2 2025.
  • Sicart Associates's portfolio value fell 1.2% quarter-over-quarter to $286M.

Based on Sicart Associates's 13F filing for Q2 2025, filed 18 Jul 2025.